INS and obesity due to melanocortin 4 receptor deficiency: However, a general conclusion that treatments that increase sphingolipid metabolites cause fat loss in animals is opposed by an experiment in mice where inhibition of ceramide de novo biosynthesis with myriocin attenuated obesity symptoms, facilitating weight reduction, better energy metabolism, and improved insulin sensitivity [18].